0,995  0,001  Respiratory analeptic
0,992  0,001  Analeptic
0,939  0,005  Apoptosis agonist
0,936  0,002  Muscle relaxant
0,931  0,002  NOS2 expression inhibitor
0,904  0,002  Skeletal muscle relaxant
0,872  0,005  Antineoplastic (breast cancer)
0,872  0,008  Transcription factor NF kappa B inhibitor
0,848  0,005  Antineoplastic (ovarian cancer)
0,847  0,004  Cardiotonic
0,843  0,005  Antineoplastic (lung cancer)
0,835  0,005  Prostate cancer treatment
0,811  0,009  CYP3A4 substrate
0,805  0,015  Antiinflammatory
0,783  0,005  Antineoplastic (melanoma)
0,778  0,003  Diuretic
0,770  0,005  Antineoplastic (cervical cancer)
0,761  0,004  Cytotoxic
0,762  0,007  Chemopreventive
0,755  0,004  Hypoxia-inducible factor 1 alpha inhibitor
0,710  0,004  UGT1A1 substrate
0,701  0,005  Heart failure treatment
0,688  0,004  Anesthetic
0,675  0,005  Antineoplastic (glioma)
0,679  0,011  Antihypercholesterolemic
0,670  0,007  Nitric oxide antagonist
0,675  0,015  Antileukemic
0,666  0,007  NOS3 expression inhibitor
0,663  0,006  UGT1A6 substrate
0,672  0,016  TNF expression inhibitor
0,659  0,003  Interleukin 6 antagonist
0,657  0,005  UGT1A4 substrate
0,660  0,011  Cholesterol antagonist
0,662  0,015  CYP2C9 substrate
0,659  0,018  Antineoplastic (colorectal cancer)
0,642  0,008  Hepatic disorders treatment
0,651  0,020  Teratogen
0,644  0,018  Antineoplastic (colon cancer)
0,617  0,003  Contraceptive
0,610  0,003  Aromatase inhibitor
0,606  0,007  UDP-glucuronosyltransferase substrate
0,591  0,004  Transcription factor STAT3 inhibitor
0,579  0,005  Antineoplastic (liver cancer)
0,577  0,004  UGT2B4 substrate
0,585  0,015  Immunosuppressant
0,583  0,013  Antineoplastic (pancreatic cancer)
0,585  0,023  Embryotoxic
0,566  0,005  Transcription factor STAT inhibitor
0,571  0,017  CYP2C19 substrate
0,557  0,005  ICAM1 expression inhibitor
0,555  0,003  Postmenopausal disorders treatment
0,562  0,014  AR expression inhibitor
0,553  0,005  UGT1A3 substrate
0,549  0,003  Mineralocorticoid receptor antagonist
0,565  0,019  Carcinogenic
0,539  0,001  Na+ K+ transporting ATPase inhibitor
0,537  0,002  Contraceptive female
0,533  0,002  UGT2B9 substrate
0,539  0,017  Cytostatic
0,520  0,004  UGT2B15 substrate
0,533  0,024  Antipruritic, allergic
0,501  0,004  Lipocortins synthesis antagonist
0,514  0,019  Antiosteoporotic
0,516  0,025  Bone diseases treatment
0,481  0,005  Sodium/bile acid cotransporter inhibitor
0,473  0,006  UGT2B7 substrate
0,482  0,016  Antineoplastic (glioblastoma multiforme)
0,484  0,020  Proliferative diseases treatment
0,474  0,016  CYP3A4 inhibitor
0,482  0,025  Antifungal
0,465  0,023  Cardiovascular analeptic
0,456  0,014  Antineoplastic (renal cancer)
0,453  0,015  Vascular (periferal) disease treatment
0,460  0,026  Antineoplastic (brain cancer)
0,454  0,027  Apoptosis antagonist
0,450  0,027  Antihypertensive
0,439  0,025  Interleukin antagonist
0,422  0,009  Prostate disorders treatment
0,422  0,011  Hepatoprotectant
0,474  0,071  Caspase 9 stimulant
0,413  0,030  Sensitization
0,414  0,032  UGT1A9 substrate
0,393  0,017  Abortion inducer
0,392  0,017  Anesthetic general
0,386  0,018  P-glycoprotein inhibitor
0,431  0,064  Antibacterial
0,370  0,008  Sulfotransferase substrate
0,372  0,014  Prostatic (benign) hyperplasia treatment
0,372  0,025  Antineoplastic (endocrine cancer)
0,348  0,006  Androgen antagonist
0,372  0,035  DNA damaging
0,375  0,039  Chemoprotective
0,379  0,044  Lipoprotein disorders treatment
0,345  0,010  Neurotrophic factor enhancer
0,365  0,034  Antihypoxic
0,343  0,014  Urolithiasis treatment
0,366  0,042  Antioxidant
0,329  0,009  Cholesterol synthesis inhibitor
0,336  0,017  Antipruritic, non-allergic
0,322  0,003  Aldosterone antagonist
0,321  0,004  VEGF expression inhibitor
0,321  0,008  Antifungal enhancer
0,340  0,035  Antiparasitic
0,316  0,015  Antiviral (Influenza A)
0,357  0,057  Caspase 3 stimulant
0,321  0,028  Antihelmintic
0,309  0,021  Antiacne
0,313  0,027  Antiviral (Influenza)
0,317  0,034  Antineoplastic (sarcoma)
0,337  0,054  CTGF expression inhibitor
0,280  0,003  Androgen agonist
0,296  0,020  Interferon gamma antagonist
0,282  0,007  UGT2B10 substrate
0,278  0,003  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,320  0,049  Renal disease treatment
0,318  0,046  Antineoplastic (lymphoma)
0,288  0,022  Hair growth stimulant
0,329  0,067  CYP2D6 substrate
0,264  0,004  Arachidonic acid antagonist
0,307  0,050  Tumour necrosis factor alpha release inhibitor
0,275  0,026  Antineoplastic (squamous cell carcinoma)
0,292  0,051  Hypolipemic
0,305  0,065  Radioprotector
0,249  0,019  Antiviral (Hepatitis B)
0,308  0,083  Antithrombotic
0,226  0,012  Choleretic
0,226  0,014  Microtubule formation inhibitor
0,206  0,005  Premenstrual syndrome treatment
0,207  0,007  Interleukin 2 antagonist
0,206  0,015  UGT2B1 substrate
0,328  0,139  Antidiabetic
0,328  0,139  Cyclophilin D inhibitor
0,192  0,005  UGT2B11 substrate
0,194  0,007  SULT1E1 substrate
0,204  0,020  Farnesoid X receptor antagonist
0,189  0,005  Anabolic
0,252  0,069  Angiogenesis stimulant
0,275  0,093  Interleukin 2 agonist
0,203  0,021  Antineoplastic antibiotic
0,216  0,035  Phospholipase C inhibitor
0,251  0,077  Antineoplastic (non-small cell lung cancer)
0,177  0,004  Glycine receptor antagonist
0,229  0,059  Mutagenic
0,209  0,047  LDLR expression enhancer
0,194  0,032  Antinephritic
0,253  0,095  Cardioprotectant
0,210  0,052  Antiviral (Hepatitis)
0,203  0,046  Liver fibrosis treatment
0,160  0,004  RNA-directed RNA polymerase stimulant
0,170  0,017  Hedgehog signaling inhibitor
0,174  0,023  Pregnane X receptor agonist
0,213  0,064  Platelet adhesion inhibitor
0,228  0,085  DNA synthesis inhibitor
0,189  0,048  Antineoplastic (carcinoma)
0,146  0,006  Anticholelithogenic
0,214  0,075  Antihypertriglyceridemic
0,219  0,082  Cardiodepressant
0,185  0,048  Melanin inhibitor
0,142  0,006  Progesterone antagonist
0,147  0,012  Estrogen agonist
0,219  0,089  Antiprotozoal (Leishmania)
0,151  0,023  Estrogen antagonist
0,172  0,046  Carcinogenic, group 3
0,124  0,003  Progesterone agonist
0,175  0,053  Amylase inhibitor
0,172  0,051  Antidiarrheal
0,167  0,046  Skin whitener
0,225  0,107  Immunostimulant
0,242  0,125  Antineoplastic (osteosarcoma)
0,159  0,045  DNA polymerase I inhibitor
0,183  0,071  Diabetic nephropathy treatment
0,148  0,036  Endometrios treatment
0,194  0,083  Psychostimulant
0,149  0,042  Growth stimulant
0,139  0,032  Antiinfertility, female
0,169  0,064  Antiviral (Herpes)
0,113  0,009  5-Alpha-reductase inhibitor
0,167  0,064  Protein-tyrosine phosphatase inhibitor
0,134  0,031  Vasculitis treatment
0,148  0,046  Protein-tyrosine phosphatase 1B inhibitor
0,224  0,123  CYP1A2 substrate
0,105  0,004  Lipocortins synthesis agonist
0,126  0,026  Estrogen receptor beta antagonist
0,131  0,034  Toll-Like receptor 4 antagonist
0,146  0,050  Antihemorrhagic
0,157  0,064  Protein kinase stimulant
0,097  0,007  Postcoital contraceptive
0,168  0,078  Toxic, respiratory center
0,124  0,036  Antineoplastic alkaloid
0,097  0,011  Estradiol 17 beta-dehydrogenase inhibitor
0,105  0,018  Glycine receptor agonist
0,087  0,005  Glucocorticoid antagonist
0,085  0,004  Glucose-6-phosphate dehydrogenase inhibitor
0,109  0,028  Contraceptive male
0,168  0,088  Antirickettsial
0,138  0,059  Antihyperlipoproteinemic
0,215  0,138  Metabolic disease treatment
0,091  0,014  SULT2A1 substrate
0,082  0,010  Acetyl-CoA transferase 2 inhibitor
0,116  0,048  Anticataract
0,102  0,034  Antibiotic
0,137  0,072  Neurotrophic factor
0,076  0,015  Estrogen receptor beta agonist
0,142  0,082  NOS3 expression enhancer
0,122  0,062  Alcohol dehydrogenase substrate
0,072  0,013  Estrogen receptor alpha agonist
0,199  0,150  Antineoplastic (multiple myeloma)
0,208  0,160  Angiogenesis inhibitor
0,125  0,078  Liver cirrhosis treatment
0,085  0,038  CDC25A inhibitor
0,062  0,017  Opioid kappa receptor agonist
0,060  0,015  Microtubule stabilization
0,054  0,010  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,168  0,125  Aldehyde oxidase inhibitor
0,084  0,042  Estrogen receptor alpha antagonist
0,053  0,013  Farnesoid X receptor agonist
0,134  0,095  Thrombolytic
0,060  0,023  Anesthetic inhalation
0,045  0,011  Tubulin agonist
0,109  0,076  Cell adhesion inhibitor
0,065  0,034  Heme oxygenase stimulant
0,046  0,015  Antihyperaldosteronism
0,046  0,015  Cholesterol absorption inhibitor
0,061  0,030  Protein 50S ribosomal subunit inhibitor
0,049  0,018  Hypogonadism treatment
0,093  0,065  Bile acid receptor antagonist
0,041  0,014  HMG CoA reductase inhibitor
0,129  0,104  Adenylate cyclase stimulant
0,171  0,147  Interleukin agonist
0,030  0,007  Corticosteroid-like
0,050  0,029  Potassium channel Kv1.3 blocker
0,047  0,027  Parathyroid hormone antagonist
0,024  0,005  Vitamin D receptor agonist
0,030  0,013  Hedgehog signaling activator
0,024  0,007  Glucocorticoid agonist
0,062  0,045  Nitric oxide donor
0,081  0,067  Transcription factor NF kappa B stimulant
0,160  0,150  VCAM1 expression inhibitor
0,044  0,036  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,070  0,063  SULT1A2 substrate
0,201  0,195  GST M1-1 substrate
0,078  0,073  T cell inhibitor
0,020  0,016  Estrone sulfatase inhibitor
0,016  0,013  Telomerase stimulant
0,012  0,009  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,006  0,004  Transcortin receptor antagonist
0,021  0,018  Vitamin D receptor antagonist
0,014  0,014  5-Alpha-reductase 1 inhibitor
0,017  0,017  Apical sodium codependent bile acid transporter inhibitor

